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Background: Cigarette smoke a recognized risk factor for many systemic diseases and also oral diseases. Human
beta defensins (HBDs), a group of important antimicrobial peptides expressed by the epithelium, are crucial for local
defense and tissue homeostasis of oral cavity. The aim of this study was to evaluate potential effects of whole
cigarette smoke (WCS) exposure on the expression and secretion of HBDs by oral mucosal epithelial cells.
Methods: Immortalized human oral mucosal epithelial (Leuk-1) cells were exposed to WCS for various time periods.
HBD-1, -2 and -3 expression and subcellular localization were detected by real time qPCR, immunofluorescence assay
and confocal microscopy. According to the relative fluorescent intensity, the expression levels of HBD-1, -2 and -3 were
evaluated by digital image analysis system. The alteration of HBD-1, -2 and -3 secretion levels was measured by the
Enzyme-Linked Immunosorbent Assay.
Results: WCS exposure remarkably attenuated HBD-1 expression and secretion while clearly enhanced HBD-2, -3
expression levels and HBD-2 secretion by Leuk-l cells. It appeared that there was no significant effect of WCS exposure
on HBD-3 secretion.
Conclusions: WCS exposure could modulate expression and secretion of HBDs by oral mucosal epithelial cells,
establishing a link between cigarette smoke and abnormal levels of antimicrobial peptides. The present results may
give a new perspective to investigate smoking-related local defense suppression and oral disease occurrence.
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Antimicrobial peptides (AMPs) are effector molecules of
the innate immune system and have antibacterial, anti-
fungal, and antiviral effects. The human defensins, one
group of small cationic AMPs, include the α-defensins
of intestinal and neutrophil origin, and the β-defensins
of skin, oral mucosa and other epithelia origin [1].
Human β defensins (HBDs) play important roles in innate
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unless otherwise stated.activity, antitumor effect, chemoattractive effect, and
immunomodulation [2]. The in vitro, in vivo and human
sample studies suggest that HBDs are important in the
biology of the oral cavity [3]. HBD-1, -2 and -3 represent
the main group of antimicrobials expressed at mucosal
surfaces by epithelial cells. HBD-1 was admitted as one of
the most important antibacterial defensins [4,5].
Cigarette smoke, recognized as a slow killer to human,
has been considered as one of unhealthy but avoidable
behaviors. All over the world, there are almost 1.3 billion
active smokers, who are thought to threaten the health
of nonsmokers by releasing secondhand smoke to the
environment. Each year about 5–6 million people die of
smoking-related diseases, such as cancers, heart diseases,
stroke, lung disorders, and gastrointestinal mucosal ulcer
[6]. The incidence and mortality of oral cancer areThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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use and heavy alcohol use [7]. In oral cavity, cigarette
smoke is also a well-recognized risk factor for periodon-
titis, oral candidiasis, and oral leukoplakia. The associ-
ation between smoking habits and the clinical subtypes
of oral lichen planus has been evaluated in a previous
study [8].
Cigarette smoke is composed of approximately 5% par-
ticulate phase and 95% vapour phase by weight. In early
studies, however, only the activity of the particulate
phase was evaluated in routine by in vitro toxicological
methods [9], which can not fully reflect the effects of
whole cigarette smoke (WCS). Therefore, the impacts of
WCS on oral epithelial cells or fibroblasts have been
focused and investigated recently. Study data from
Gualerzi et al. indicated that WCS had acute effects on
epithelial intercellular adhesion and terminal differenti-
ation of keratinocytes in a three-dimensional model of hu-
man oral mucosa [10]. A study of Semlali and colleagues
revealed that WCS promoted human gingival epithelial
cell apoptosis and inhibited cell repair processes [11].
Another study of Semlali et al. demonstrated that a sin-
gle exposure to WCS produced significant morpho-
logical and functional deregulation in gingival
fibroblasts [12]. The report of Colombo et al. also deter-
mined that WCS exposure resulted in oxidative damage
in human gingival fibroblasts [13].
A more recent study from Pierson and colleagues con-
firmed that cigarette smoke extract induced differential
expression levels of HBDs in human alveolar epithelial
cells [14]. The study results of Semlali et al. suggested
that WCS exposure up-regulated mRNA levels and pro-
tein production of HBD-2 and HBD-3 by human gin-
gival epithelial cells [15]. As cigarette smoke enters the
organism through the mouth, the anatomical cytoarchi-
tecture of the oral mucosa is essential in providing a bar-
rier to counteract potential harmful consequences on
the whole organism [10]. HBDs are crucial for local
defense and tissue homeostasis of oral cavity. However,
the effects of WCS on the expression and secretion of
HBDs by oral mucosal epithelial cells are still unclear.
Therefore, the present study was designed to evaluate
the alteration of the expression and secretion of HBDs
by human oral mucosal epithelial cells exposed to WCS.
Methods
Cell line and cell culture
Immortalized human oral mucosal epithelial (Leuk-1)
cell line was obtained from Professor Li Mao (Depart-
ment of Oncology and Diagnostic Sciences, University of
Maryland Dental School, Baltimore, MD, USA). Leuk-1
cells were maintained and passaged in defined keratino-
cyte serum-free medium (K-SFM) (GIBCO, Invitrogen,
Grand Island, NY, USA) in a humidified incubator with5% CO2 at 37°C. This medium was supplemented with
Bovine Pituitary Extract (BPE) (25 ug/ml), epidermal
growth factor (0.2 ng/ml), CaCl2 (0.4 mM).
Whole cigarette smoke exposure
First, Leuk-1 cells were seeded onto the porous membrane
of Transwell™ inserts (Transwell, Corning, Schipho-Rijk,
Netherlands). Cells were cultured at 37°C prior to WCS
treatment. After 24 h, the Transwell™ inserts were taken
out and transferred into a WCS exposure chamber
(Figure 1A). As previously described [9,16-20], the
WCS exposure chamber (UK patent publication WO
03/100417/ A1, British American Tobacco, UK) was
used to expose cell cultures to mainstream cigarette
smoke. The temperature inside the chamber remained
stable. The chamber can accommodate 6 × 12 mm inserts,
which allow cells to grow on the porous membrane at the
air-liquid interface. The cells were cultured on Transwell™
inserts which were housed in the exposure chamber and
were exposed apically to evenly distributed cigarette smoke.
Kentucky 3R4F research-reference filtered cigarettes
(The Tobacco Research Institute, University of Kentucky,
Lexington, KY), one of which contains 0.73 mg of nicotine
and 9.4 mg of tar, were used in the present study. A peri-
staltic pump (LongerPumper, USA) was used to control
the speed of smoke import at 20 rpm. Cigarette smoke
was exhausted in the chamber and old smoke was re-
placed by fresh smoke from the next puff. A peristaltic
pump was adopted to regulate the contact relationship be-
tween the media and porous membrane, which prevented
flooding of the cell monolayer and disruption of the air-
liquid interface. Fresh media were introduced basally and
used media were drained away from the chamber by a
peristaltic pump at 80 rpm. Media flow is unidirectional
to avoid build up of smoke toxicants, which may affect ex-
posure conditions basally. Following WCS exposure, the
Transwell™ inserts were transferred to a 12-well plate as
before at 37°C in 5% CO2 for 6 h. Figure 1B showed a
schematic of the in vitro WCS exposure apparatus.
In the experimental group, cell cultures were exposed
to WCS for 5 min, 10 min, 20 min, and 40 min, respect-
ively. Based on our preliminary study, the results confirmed
that there was no significant difference in expression and
secretion levels of HBD-1, -2 and -3 of Leuk-1 cells ex-
posed to filtered air for 5 min, 10 min, 20 min, and 40 min.
Thus, cell cultures exposed to filtered air for 10 min were
set as the control group.
Real time quantitative reverse transcription PCR
(qRT-PCR)
Total cellular RNA was extracted by using TRIzol re-
agent (Invitrogen, Carlsbad, CA, USA) and 2 μg of RNA
was used to synthesize the first-strand cDNA in 20 μl of
reaction volume using RevertAid First Strand cDNA
Figure 1 Whole cigarette smoke (WCS) exposure apparatus. A. WCS exposure chamber (British American Tobacco). B. The schematic of WCS
exposure apparatus used in the present study.
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ing to the manufacturer’s protocols. Real-time PCR ana-
lyses ware performed using an ABI 7300 Real Time PCR
System (Applied Biosystem, Foster City, CA), and PCR
amplifications were performed using the SYBR Green
PCR Master Mix (Roche, Mannheim, Germany) accord-
ing to the manufacturer’s instruction. Amplification con-
ditions were as follows: 50°C for 2 min, 95°C for 10 min,
40 cycles of 95°C for 15 s, 58°C for 30 s, and 72°C for
30 s, followed by melting curve analysis, by which the
specificity of primers was confirmed. The data are
expressed as relative mRNA levels and were normalized
to GAPDH. Fold changes in expression of each gene
were calculated by a comparative threshold cycle (Ct)
method using the formula 2−(ΔΔCt). The experiment was
repeated three times. The primers used for the PCR am-
plifications are listed as follows: HBD-1 forward TCA
TTA CAA TTG CGT CAG CAG, reverse TTG CAG
CAC TTG GCC TTC [21]; HBD-2 forward TCC TCT
TCT CGT TCC TCT TCA, reverse AGG GCA AAA
GAC TGG ATG AC [21]; HBD-3 forward CCA TTA
TCT TCT GTT TGC TTT GCT C, reverse CCG CCT
CTG ACT CTG CAA TAA TA [22]; GAPDH forwardGCA CCG TCA AGG CTG AGA AC, reverse TGG
TGA AGA CGC CAG TGG A [23].
Immunofluorescence and confocal microscopy
To evaluate intracellular expression levels of HBD-1, -2
and -3 by using immunofluorescence and confocal mi-
croscopy, Leuk-1 cells were cultured on glass coverslips
for 24 h. Then each coverslip was transferred onto the
bottom of TranswellTM insert, respectively. Subsequently,
Leuk-1 cells on coverslips were exposed with WCS or fil-
tered air (control) in above-mentioned exposure chamber.
Following treatment, Leuk-1 cells on coverslips were re-
covered in fresh K-SFM at 37°C for 6 h. Next, Leuk-1 cells
on coverslips were washed with PBS and fixed in 4% para-
formaldehyde for 15 min at room temperature. After be-
ing washed in PBS, the cells were permeabilized in 0.5%
(v/v) Triton X-100 in PBS, washed, and blocked with 5%
BSA in PBS-0.1% Tween 20 for 1 h at 37°C. Next, the
cells were exposed overnight at 4°C to primary anti-
bodies. Primary antibodies against the following proteins
were used: mouse anti-HBD-1 antibody (1:100), and rabbit
anti- HBD-2 antibody (1:100) were purchased from
Abcam (Cambridge, UK); rabbit anti-HBD-3 antibody
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USA). The next day, coverslips were washed with PBS
and then incubated with Dylight 488 (green)-labeled
goat-anti-mouse secondary antibody or Alexa Fluor
555 (red)-labeled goat-anti-rabbit secondary antibody
for 1 h at room temperature. To stain the nuclei, 1 μg/ml
(w/v) 4′, 6-diamidino-2-phenylindole (DAPI, Sigma, USA)
was added for 5 min, and slides were examined by a
confocal laser scanning microscope (FluoView FV10i,
Olympus, Japan).
Digital image analysis
Digital image analysis of immunostaining results was
performed as described previously with minor modifica-
tion [24]. Altered intracellular levels of HBD-1, -2 and -3
were evaluated by fluorimetry in Leuk-1 cells. Fluores-
cence imaging experiments were performed at room
temperature and images were acquired with confocal
laser scanning microscope (FluoView FV10i, Olympus,
Japan), with a 600 × objective. Images were analyzed
with the Image J software. Values represent the average
of the mean fluorescence intensity measured in ran-
domly distributed fields (each field represented a region
of interest, ROI) selected on independent coverslips (10
ROIs for each coverslip). All ROIs were of the same size
in the experiment. ROIs always included multiple cells
and only adherent cells were considered in the analysis.
In the current study, the relative fluorescence intensity
was used to represent expression levels of HBD-1, -2
and -3. The relative fluorescence intensity in control
group was considered as “1.0”. The ratio of the mean
fluorescence intensity of each exposure group to that of
control group was regarded as the relative fluorescence
intensity of corresponding exposure group.
Subcellular localization of HBD-1, -2 and -3
Leuk-1 cells grown on coverslips were exposed with
WCS or filtered air (control) in Transwell™ inserts. Fol-
lowing treatment, Leuk-1 cells on coverslips were recov-
ered in fresh K-SFM at 37°C for 6 h. Immunofluorescence
staining was performed as above-mentioned methods.
Subcellular localization of HBD-1, -2 and -3 in Leuk-1
cells was detected using confocal microscopy.
Enzyme-linked immunosorbent assay (ELISA)
To further study the effects of WCS exposure on HBDs
releases from human oral epithelial cells, ELISA assays
were performed to detect HBDs levels in the supernatant
of Leuk-1 cells culture following WCS exposure. First,
Leuk-1 cells were seeded onto the porous membrane of
Transwell™ inserts at a density of 3 × 105 cells/well in
0.5 ml of K-SFM medium, which were inserted into a
12-well plate. Then K-SFM was added into the underlayerwells for 1.5 ml per well. Cells were cultured at 37°C for
prior to WCS treatment. After 24 h, the inserts were taken
out and transferred into the WCS exposure chamber. Fol-
lowing WCS exposure, the inserts were transferred into a
12-well plate as before at 37°C in 5% CO2 for 6 h.
To detect the amount of HBD-1, -2 and -3 secreted by
Leuk-1 cells, ELISA kits were used to measure the levels
of HBD-1, -2 and -3 in cell culture supernatant. The
HBD-1, -2 and -3 ELISA Kits were purchased from Jing-
tian (Shanghai, China). HBD-1, -2 and -3 standard sub-
stances for controls (3200 pg/ml) were used to
construct standard curves (Jingtian, Shanghai, China).
HBD-1, -2 and -3 levels in leuk1 cell supernatant were
measured according to the manufacturer’s protocols.
Absorbances were read at 450 nm and 570 nm using a
microplate reader, the absorbance at 570 nm was sub-
tracted from the absorbance at 450 nm.Statistical analysis
Statistical analysis was performed using SPSS 15.0. Data
are presented as mean ± SE. Significance was analyzed
using the Student’s t-test or One-Way ANVOA test.
P value less than 0.05 was considered significant.Results
WCS exposure down-regulated mRNA level of HBD-1
and up-regulated mRNA levels of HBD-2 and -3 in
Leuk-1 cells
The qRT-PCR results indicated that HBD-1 mRNA level
was markedly down-regulated in Leuk-1 cells following
20 min- and 40 min-WCS exposure compared with
control (P < 0.01 and P < 0.05, respectively) (Figure 2A).
Our present data also suggested that HBD-2 mRNA
level was dramatically up-regulated in Leuk-1 cells fol-
lowing 20 min- and 40 min-WCS exposure compared
with control (P < 0.001 and P < 0.01, respectively) (Figure 2B).
HBD-3 mRNA level was remarkably up-regulated in Leuk-1
cells following 10 min-, 20 min- and 40 min-WCS exposure
compared with control (P < 0.05, P < 0.05, and P < 0.01,
respectively) (Figure 2C).WCS exposure reduced protein level of HBD-1 in Leuk-1
cells
As these proteins of HBD-1, -2 and -3 have extremely
small size (about 4 ~ 7 kD), the immunoblotting of HBDs
remains a challenge. Thus, the immunofluorescence assay
and digital image analysis were preformed in the present
study to access the protein levels of HBD-1, -2 and -3. As
shown in Figure 3, HBD-1 level significantly decreased in
Leuk-1 cells following 10 min-, 20 min-, or 40 min-WCS
exposure compared with control (P < 0.001, P < 0.001, and
P < 0.001, respectively).
Figure 2 WCS exposure down-regulated HBD-1 mRNA level and up-regulated HBD-2, −3 mRNA levels in Leuk-1 cells. HBD-1, −2 and −3
mRNA levels were assayed by qRT-PCR. A. HBD-1 mRNA level was markedly down-regulated in Leuk-1 cells following 20 min- and 40 min-WCS
exposure compared with control. B. HBD-2 mRNA level was dramatically up-regulated in Leuk-1 cells following 20 min- and 40 min-WCS exposure
compared with control. C. HBD-3 mRNA level was remarkably up-regulated in Leuk-1 cells following 10 min-, 20 min- and 40 min-WCS exposure
compared with control. The qPCR data were expressed as means ± SE (n = 3). Statistical significance: *P < 0.05, vs. control; **P < 0.01, vs. control;
***P < 0.001, vs. control.
Wang et al. Tobacco Induced Diseases  (2015) 13:3 Page 5 of 10WCS exposure increased protein levels of HBD-2 and
HBD-3 in Leuk-1 cells
In the present study, our results indicated that HBD-2
level remarkably increased in Leuk-1 cells following
20 min- and 40 min-WCS exposure compared with
control (P < 0.01 and P < 0.01, respectively) (Figure 4).
Our data also suggested that HBD-3 level markedly
augmented in Leuk-1 cells following 10 min-, 20 min- and
40 min-WCS exposure compared with control (P < 0.01,
P < 0.001, and P < 0.01, respectively) (Figure 5).
Subcellular localization of HBD-1, -2, and -3
Through immunofluorescence and confocal microscopy,
the subcellular localization of HBD-1, -2, and -3 in
Leuk-1 cells was determined in the present study. TheFigure 3 WCS exposure reduced HBD-1 level in Leuk-1 cells. A. Repres
in control group and WCS exposure groups. Scale bar = 50 μm. B. The relat
HBD-1. HBD-1 level significantly decreased in Leuk-1 cells following 10 min
significance: ***P < 0.001, vs. control.subcellular localization of HBD-1 was mainly in peri-
nuclear cytoplasm and nuclei. Reticular immunostaining
of HBD-1 was clearly observed in perinuclear cytoplasm
and strong expression of HBD-1 was especially noted in
nucleoli area. Following 40 min-WCS exposure, how-
ever, the expression of HBD-1 in perinuclear cytoplasm
almost disappeared and the expression of HBD-1 in nu-
cleoli area was weak (Figure 6A).
The weak expression of HBD-2 was observed mainly
in perinuclear cytoplasm. Some expression of HBD-2
could also be detected in cytoplasmic vesicles. Following
40 min-WCS exposure, the expression of HBD-2 local-
ized in perinuclear cytoplasm dramatically enhanced and
(Figure 6B). The subcellular localization of HBD-3 was
mainly in perinuclear cytoplasm and nucleoli area, whichentative immunofluorescence stainings of HBD-1 (green) in Leuk-1 cells
ive fluorescence intensity was used to represent protein level of
-, 20 min- and 40 min-WCS exposure compared with control. Statistical
Figure 4 WCS exposure increased HBD-2 level in Leuk-1 cells. A. Representative immunofluorescence stainings of HBD-2 (red) in Leuk-1 cells
in control group and WCS exposure groups. Scale bar = 50 μm. B. The relative fluorescence intensity was used to represent protein level of HBD-2.
HBD-2 level remarkably increased in Leuk-1 cells following 20 min- and 40 min-WCS exposure compared with control. Statistical significance:
**P < 0.01, vs. control.
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the expression of HBD-3 dramatically augmented and
still localized in perinuclear cytoplasm and nucleoli area
(Figure 6C).
WCS exposure attenuated HBD-1 secretion by Leuk-l cells
As shown in Figure 7, compared with the basal secretion
in control group, 10 min- and 20 min-WCS exposure in-
duced clear down-regulation of HBD-1 secretion by Leuk-1Figure 5 WCS exposure augmented HBD-3 level in Leuk-1 cells. A. Re
cells in control group and WCS exposure groups. Scale bar = 50 μm. B. The
HBD-3. HBD-3 level was markedly augmented in Leuk-1 cells following 10 m
Statistical significance: **P < 0.01, vs. control; ***P < 0.001, vs. control.cells (P < 0.05 and P < 0.05, respectively). Moreover 40 min-
WCS exposure dramatically attenuated HBD-1 secretion by
Leuk-1 cells compared with the control group (P < 0.01).
Alteration of the secretion of HBD-2 and HBD-3 by Leuk-1
after WCS exposure
As shown in Figure 7, compared the basal secretion in
control group, 20 min- and 40 min-WCS exposure sig-
nificantly enhanced HBD-2 secretion by Leuk-1 cellspresentative immunofluorescence stainings of HBD-3 (red) in Leuk-1
relative fluorescence intensity was used to represent protein level of
in-, 20 min- and 40 min-WCS exposure compared with control.
Figure 6 Subcellular localization of HBD-1, -2 and -3 in Leuk-1
cells. A. HBD-1 (green) was mainly localized in perinuclear cytoplasm
and nuclei. Reticular immunostaining of HBD-1 was clearly observed
in perinuclear cytoplasm (asterisk) and strong expression of HBD-1
was especially noted in nucleoli area (closed arrowhead). Following
40 min-WCS exposure, reticular immunostaining of HBD-1 in peri-
nuclear cytoplasm nearly disappeared and the expression of HBD-1
in nucleoli area was weak (closed arrowhead). B. The weak expression
of HBD-2 (red) was mainly in perinuclear cytoplasm. Some expression
of HBD-2 could also be detected in cytoplasmic vesicles (arrow).
Following 40 min-WCS exposure, the expression of HBD-2 dramatically
enhanced and localized in perinuclear cytoplasm. C. HBD-3 (red) was
mainly localized in perinuclear cytoplasm and nucleoli area (open
arrowhead), which was expressed weakly. Following 40 min-WCS
exposure, the expression of HBD-3 dramatically augmented and
still localized in perinuclear cytoplasm and nucleoli area (open
arrowhead). Scale bar = 20 μm.
Figure 7 WCS exposure attenuated HBD-1 secretion and enhanced
HBD-2 secretion by Leuk-l cells. Compared with the basal secretion
level in control group, 10 min-, 20 min- and 40 min-WCS exposure
induced significant down-regulation of HBD-1 secretion by Leuk-1 cells.
Compared with the basal secretion level in control group, 20 min- and
40 min-WCS exposure significantly enhanced HBD-2 secretion by Leuk-1
cells. There was no significant difference of HBD-3 secretion between
WCS exposure groups and control group. ELISA data were expressed
as means ± SE (n = 12/group). Statistical significance: *P < 0.05, vs.
control; **P < 0.01, vs. control.
Wang et al. Tobacco Induced Diseases  (2015) 13:3 Page 7 of 10(P < 0.05 and P < 0.05, respectively). No significant dif-
ference of HBD-3 secretion was found between WCS
exposure groups and control group.
Discussion
Mainstream cigarette smoke is an aerosol consisting of a
gas/vapor and particulate phase which contains over4,000 individual chemical constituents [25]. Tradition-
ally, two main methods of cigarette smoke exposure are
used for in vitro studies. One method is to collect the
particulate phase with a Cambridge filter pad, which is
referred to as total particulate matter (TPM) or cigarette
smoke condensate (CSC). The other method is to isolate
water-soluble cigarette smoke components from both
particulate and gas phases by bubbling cigarette smoke
through PBS or cell culture medium, which is referred
to as aqueous cigarette smoke extract (CSE). However,
both two methods of collecting smoke phases have limi-
tations. Capturing particulate fraction neglects the gas
phase components of the mixture, while bubbling of
cigarette mainstream smoke through PBS or medium
fails to capture a significant amount of the particulate
phase [26].
To better understand the toxicological and biological
effects of cigarette smoke, the exposure system of WCS
which consists of particulate and gas/vapor phase, has
been developed in the past decade. A novel WCS ex-
posure system has been established and designed to
expose human epithelial cells cultured on Transwell™
inserts to mainstream WCS (UK patent publication
WO 03/100417/ A1) [9,16-20]. This system allows all
phases of cigarette smoke including particulate and gas
to be assessed in combination.
All the cells within oral cavity are the first to be ex-
posed to cigarette smoke and oral cavity may be a poten-
tial approach for the spread of toxins to other organs of
the body [27]. Upon entrance into the oral cavity,
cigarette smoke reaches the oral mucosa where epithelial
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in maintaining host homeostasis. Alike to other micro-
bial barriers, oral mucosal epithelial cells play a critical
role in host defense and innate immune. Previously pub-
lished results demonstrated the role of HBDs in main-
taining homeostatic levels of commensal bacteria, in
protecting against colonization of pathogenic microbes,
both under constitutive circumstances, and in response
to the interaction of the pathogen with the epithelial cell
[3]. These strongly supported the crucially defensive role
of HBDs in the oral cavity. Although 28 HBDs have been
found till now, the expression and effects of HBD-1, -2
and -3 have been most investigated [28].
In the present study, our results revealed for the first
time that WCS exposure attenuated HBD-1 expression
and secretion by human oral mucosal epithelial cells.
Wolgin et al. found that the mRNA level of HBD-1 was
significantly reduced in gingival samples from smokers
compared to that from non-smokers [21]. Shibata et al.
determined that the mRNA level of mouse β defensin
(mBD)-1, a functional homolog of HBD-1, decreased in
the lungs of cigarette smoke-exposed mice compared
with that of air-exposed mice [29]. As one of the most
important AMP in epithelial cells, HBD-1 is thought to
be constitutively expressed and persistently secreted by
various epithelial cells of many organs [4,30]. It has been
well demonstrated that HBD-1 played crucial roles in
antitumor, antimicrobial activity, homeostasis mainten-
ance, wound healing, and immunomodulatory effect.
Based on existed evidences, the present results may give
a new clue to understand smoking-related local defense
suppression and oral diseases occurrence.
In the present study, our results showed that WCS ex-
posure enhanced the expression of HBD-2 and HBD-3
and augmented HBD-2 secretion by human oral mucosal
epithelial cells. The data of Semlali et al. suggested that
WCS exposure for 15–30 min increased mRNA levels
and protein production of HBD-2 and HBD-3 by human
gingival epithelial cells [15]. The results of Shibata et al.
indicated that mBD-2 and mBD-3 expression increased
in the lungs of cigarette smoke-exposed mice compared
with air-exposed mice [29]. The study results of Chen
et al. indicated that cigarette smoke enhanced rat β
defensin (rBD)-2 expression in rat airways via NF-κB ac-
tivation [31]. Normally, only a small amount HBD-2 and
HBD-3 express in epithelial cells. HBD-2 and HBD-3
could be induced by pathogenic bacteria and proinflam-
matory cytokines, such as TNF-α, IL-1β, IFN-γ [28,32].
Our current results are consistent with the previous data
in the literature and supported that WCS exposure could
up-regulate HBD-2 and HBD-3 expression. Semlali et al.
found that WCS exposure promoted HBD-2, HBD-3,
IL-1β, and IL-6 expression through the ERK1/2 and NF-κB
pathways. The increased expression of HBD-2 and HBD-3following WCS exposure might be due to proinflamma-
tory response of cells [15]. Cigarette smoke may directly
stimulate novel HBDs production, leading to enhance-
ment of IL-1β, which in turn could further stimulate
additional HBDs production, in a paracrine or autocrine
loop [14]. Stimulation of oral squamous cell carcinoma
(BHY-OSCC) cell line with HBD-1 resulted in reduction
of cell proliferation, whereas HBD-2 and HBD-3 stimu-
lation caused promotion of cell proliferation, indicating
that HBD-1 might function as a tumor suppressor gene,
while hBD-2 and -3 might be protooncogenes in OSCC
[33]. Exposure to cigarette smoke is thought to be harmful
to host respiratory defenses through multiple modes of ac-
tion [34]. Our present results revealed that WCS exposure
had differential effects on expression and secretion of
HBDs by oral mucosal epithelial cells, suggesting cigarette
smoke-induced abnormal expression of HBDs is involved
in some oral diseases and should be further investigated
mechanistically.
Some present data on HBD-2 and HBD-3 were not in
agreement with some of previous reports. Wolgin et al.
found that the mRNA level of HBD-2 was significantly
reduced in gingival samples of smokers compared to
that of non-smokers [21]. Mahanonda et al. reported
that CSE markedly reduced Porphyromonas gingivalis
lipopolysaccharide-stimulated HBD-2 expression in hu-
man gingival epithelial cells in vitro [35]. The study
results of Semlali et al. suggested that WCS exposure
significantly augmented the secretion of HBD-3 by hu-
man gingival epithelial cells. These conflicting findings
between the literature and the present study may be
partly explained by the difference between human tissue
specimen and cell culture. Generally, influencing factors
in in vitro study are much fewer than that in in vivo
study, which include systemic factors, immunomodula-
tion, microorganisms, quantitation of cigarette smoke
treatment, etc. Furthermore, the experimental model
and cell type used in each study may be of considerable
importance [15]. CSE and WCS exposure may induce
different responses of cells. Similarly, different study
apparatuses or methods of WCS exposure may also
lead to potentially conflicting results.
In the present results, the difference of altered extent
of HBDs levels was observed between the expression level
in Leuk-1 cells and the secretory level in supernatant of
cell culture. The altered extent of HBDs at secretory level
was more minor than that at expression level. WCS ex-
posure remarkably enhanced the expression HBD-3,
while the secretion of HBD-3 seemed not to be signifi-
cantly impacted. Mainly, the difference could result
from the regulation of antimicrobial peptide expression
at transcriptional, post-transcriptional and post-translational
levels [36,37]. Additionally, this difference may be ex-
plained that only a part of intracellular HBDs could be
Wang et al. Tobacco Induced Diseases  (2015) 13:3 Page 9 of 10released into supernatant of cell culture. In the post-
translational translocation process, the synthesis and
translocation of the preproteins are uncoupled [38]. By
potentially modulating the production and release of
HBDs and other antimicrobial peptides, oral mucosal
epithelial cells might construct and control the defen-
sive response system to microbe.
Conclusion
The present study revealed that WCS exposure could
modulate HBDs expression and secretion by oral mucosal
epithelial cells, which might be a link between cigarette
smoke and oral diseases. Establishing a relationship be-
tween smoking and abnormal levels of antimicrobial pep-
tides is crucial to understand local defense dysfunction in
cigarette smokers, which might provide a new perspective
to interpret the pathology of tobacco-induced diseases.
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